Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma
Authors
Keywords
-
Journal
TUMOR BIOLOGY
Volume 39, Issue 7, Pages 101042831770737
Publisher
SAGE Publications
Online
2017-07-20
DOI
10.1177/1010428317707372
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Renal cancer subtypes: Should we be lumping or splitting for therapeutic decision making?
- (2016) Scott M. Haake et al. CANCER
- Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy
- (2016) Yu Ren et al. JOURNAL OF CONTROLLED RELEASE
- MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression
- (2016) Chang Li et al. Oncotarget
- MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulatingPTENandPDCD4
- (2016) Xueju Wei et al. Cancer Medicine
- Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel
- (2015) Bo Jin et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Cancer stem cell: Fundamental experimental pathological concepts and updates
- (2015) Farhadul Islam et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- MicroRNA-21 stimulates epithelial-to-mesenchymal transition and tumorigenesis in clear cell renal cells
- (2015) JIAN CAO et al. Molecular Medicine Reports
- Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer
- (2015) Vahid Haghpanah et al. TUMOR BIOLOGY
- Cancer-associated fibroblasts promote renal cell carcinoma progression
- (2015) Yunze Xu et al. TUMOR BIOLOGY
- MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway
- (2015) Changjun He et al. Oncotarget
- Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis
- (2015) Kun Tang et al. Scientific Reports
- Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth
- (2015) David Vindrieux et al. Oncotarget
- MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathway
- (2015) Audrey Bouillez et al. Oncotarget
- MUC1 drives epithelial–mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter
- (2014) Viviane Gnemmi et al. CANCER LETTERS
- miR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4
- (2014) Wenhao Ren et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer
- (2014) Hua Shen et al. PLoS One
- FibromiRs: translating molecular discoveries into new anti-fibrotic drugs
- (2014) Nicolas Pottier et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro
- (2013) Jun Deng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway
- (2013) Ai-Mei Gao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Increased Circulating miR-21 Levels Are Associated with Kidney Fibrosis
- (2013) François Glowacki et al. PLoS One
- MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma
- (2012) Pedro M. Costa et al. HUMAN MOLECULAR GENETICS
- Inhibition of IGF-IR increases chemosensitivity in human colorectal cancer cells through MRP-2 promoter suppression
- (2012) Ke Shen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The Clinical Utility of miR-21 as a Diagnostic and Prognostic Marker for Renal Cell Carcinoma
- (2012) Hala Faragalla et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients
- (2009) Sujata Patil et al. CANCER
- MUC1, a New Hypoxia Inducible Factor Target Gene, Is an Actor in Clear Renal Cell Carcinoma Tumor Progression
- (2009) S. Aubert et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search